hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Avicanna Inc.
Announced the United States Patent and Trademark Office issuance of the Patent covering Avicanna’s SEDDS oral cannabinoid compositions and methods for treating neuropathic pain. Avicanna Inc. shares T.AVCN are trading up $0.01 at $0.27.
